The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics
- 1 December 2010
- journal article
- review article
- Published by Elsevier in Microbes and Infection
- Vol. 12 (14-15) , 1144-1152
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virusCytokine & Growth Factor Reviews, 2010
- Toll-like receptor signaling in cell proliferation and survivalCytokine, 2010
- Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cellsLeukemia, 2009
- Myxoma Virus Expressing Interleukin-15 Fails To Cause Lethal Myxomatosis in European RabbitsJournal of Virology, 2009
- Protein kinase R reveals an evolutionary model for defeating viral mimicryNature, 2008
- Protein kinase PKR mutants resistant to the poxvirus pseudosubstrate K3L proteinProceedings of the National Academy of Sciences, 2008
- Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKε‐mediated IRF activationThe EMBO Journal, 2008
- Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7LVirology, 2008
- Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic proteinJournal of General Virology, 2007
- Vaccinia virus N1L protein resembles a B cell lymphoma‐2 (Bcl‐2) family proteinProtein Science, 2007